Global Latex Allergy Market Size, Share, Forecast Report, 2020-2027

Latex allergy is caused by exposure to substances made of latex (natural rubber). The exposure leads to a person’s immune system reaction to harmless protein in such a way as if the proteins are antigens, or disease causing. Antibodies and antihistamines get released in the body as result so as to react to the natural harmless proteins which may cause symptoms such as itchy hands, skin rash, hives, and eczema (cracking of skin). It is commonly caused in people who are exposed to latex based products frequently. The market for latex allergy is growing due to increase in the prevalence of such allergy giving rise to other diseases such as Asthama, Rhinitis, Anaphylaxis and such others. The global market for latex allergy is expected to reach US$ XX by the end of the forecasted period. And this market is expected to grow at a CAGR of XX% every year.
Key Players for Latex Allergy Market:
Some of the key players in this market are: 3M, Alcon Inc., Allerayde UK Ltd, Allergy Hero, Array, BioPharma Inc, AstraZeneca, Aterica, Boehringer-Ingelheim, Dey Labs, GlaxoSmithKline, Johnson & Johnson, Merck, Nektar Therapeutics, Novartis AG, Rocky Mountain Diagnostics, and Sanofi
Segments:

Latex Allergy Market has been segmented on the basis of type of exposure the market is segmented as latex gloves, food containing latex substances. On the basis of diagnosis type the market is segmented as skin test and allergy test. On the basis of reaction type the market is segmented as Systemic Reaction, Allergic contact dermatitis, Irritant Contact dermatitis, Asthama, Anaphylaxis, and Rhinitis. On the basis of type of treatment, the market is segmented into Epinephrine injection, Allergy medications: Inhaler/albuterol, antihistamine, asthma medication, Corticosteroids etc.